AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 3422553
Drug: Ethanol (1.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ethanol (1.1 mL/kg)
Trial: 25311594
Drug: Intensive voice
RxNorm normalized name: Uricalm Intensive
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intensive voice therapy
Trial: 31630089
Drug: Cognitive Functional
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive Functional Therapy (CFT)
Trial: 31427344
Drug: Cognitive Functional
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive Functional Therapy plus movement sensor biofeedback
Trial: 15774791
Drug: Standard chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard chemotherapy + muramyl tripeptide (MTP)
Trial: 15774791
Drug: Standard chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard chemotherapy + ifosfamide
Trial: 7722020
Drug: Terbinafine 250
RxNorm normalized name: terbinafine 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Terbinafine 250 mg/day for 16 weeks
Trial: 7722020
Drug: Griseofulvin 500
RxNorm normalized name: griseofulvin 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Griseofulvin 500 mg/day for 52 weeks
Trial: 2351367
Drug: 8 mg
RxNorm normalized name: alloin 8 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 8 mg of perindopril tert‐butylamine salt by oral route (treatment A)
Trial: 2351367
Drug: Intravenous route
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous route (bolus in 5 min, treatment B)
Trial: 2351367
Drug: Equimolar dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Equimolar dose of perindoprilat (6.1 mg) by intravenous route (infusion over 2 h, treatment C)
Trial: 30385649
Drug: Very Low
RxNorm normalized name: Very low fat spread
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Very Low Nicotine Content (VLNC) cigarettes (0.4 mg nicotine/g tobacco)
Trial: 31867650
Drug: Normal nicotine
RxNorm normalized name: Nicotine
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Normal nicotine content cigarettes (15.8 mg/g)
Trial: 18378608
Drug: Celecoxib 200
RxNorm normalized name: celecoxib 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Celecoxib 200 mg BID
Trial: 17460158
Drug: Naproxen sodium
RxNorm normalized name: Naproxen Sodium
DrugBank: Naproxen (DB00788)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Naproxen sodium 220 mg BID
Trial: 14693591
Drug: 45 mg
RxNorm normalized name: lutein 45 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 45 mg 2-chloroprocaine with epinephrine
Trial: 350495
Drug: Aspirin (3.9
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin (3.9 g daily)
Trial: 31422655
Drug: 10 mL
RxNorm normalized name: Vial Empty 10 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mL of 0.25% bupivacaine
Trial: 11473840
Drug: 10 mL
RxNorm normalized name: Vial Empty 10 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mL of 1% lidocaine
Trial: 31422655
Drug: 5 mL
RxNorm normalized name: WATER,INHL 5 ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mL of 0.25% bupivacaine plus 5 mL of 1% lidocaine
Trial: 23850416
Drug: HSV vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HSV vaccine (AS04-adjuvanted herpes simplex virus type 2 glycoprotein D subunit vaccine)
Trial: 23850416
Drug: Hepatitis A
RxNorm normalized name: HEPATITIS A
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hepatitis A vaccine (Havrix™; HAV control)
Trial: 19824016
Drug: 25 g
RxNorm normalized name: AndroGel 1.25 g Packets
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25 g unground flaxseed
Trial: 19824016
Drug: 25 g
RxNorm normalized name: AndroGel 1.25 g Packets
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25 g sesame seed
Trial: 19824016
Drug: 12.5 g
RxNorm normalized name: glycerin 12.5 GM per 20.4 ML Enema
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 12.5 g unground flaxseed + 12.5 g sesame seed (flaxseed+sesame seed bar, FSB)
Trial: 19242131
Drug: 40 mL/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mL/kg of fluid over 15 minutes followed by dopamine
Trial: 19242131
Drug: 20 mL/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mL/kg over 20 minutes up to a maximum of 60 mL/kg over 1 hour followed by dopamine
Trial: 15198901
Drug: GOS supplemented
RxNorm normalized name: Go-dry
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GOS supplemented formula (0.24 g/dl)
Trial: 12374874
Drug: Heparin plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin plus placebo
Trial: 234668
Drug: Timolol (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Timolol (30 mg per day)
Trial: 6130038
Drug: Propranolol (120
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol (120 mg per day)
Trial: 27025337
Drug: Empirical tuberculosis
RxNorm normalized name: Mycobacterium tuberculosis
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Empirical tuberculosis therapy
Trial: 23954450
Drug: Isoniazid preventive
RxNorm normalized name: Isoniazid
DrugBank: Isoniazid (DB00951)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Isoniazid preventive therapy
Trial: 22697273
Drug: Co-administration of
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Co-administration of Lobeglitazone and Metformin
Trial: 17361245
Drug: Combined treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined treatment periods for timolol GFS
Trial: 16379620
Drug: AIR pulmonary
RxNorm normalized name: air
DrugBank: Medical air (DB09337)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AIR pulmonary delivery system (5-mg placebo powder of engineered particles)
Trial: 18540781
Drug: Olanzapine 5.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Olanzapine 5.0 mg
Trial: 6144462
Drug: Lorazepam 1.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lorazepam 1.0 mg
Trial: 9860397
Drug: CCK-8 infused
RxNorm normalized name: CCK-8
DrugBank: Sincalide (DB09142)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: CCK-8 infused intravenously (i.v.) at physiological doses
Trial: 9860397
Drug: Loxiglumide (CCK-A
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Loxiglumide (CCK-A receptor antagonist) pretreatment
Trial: 7658089
Drug: CVD 112
RxNorm normalized name: Vibrio cholerae CVD 103-HGR strain live antigen Oral Suspension [Vaxchora]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CVD 112 vaccine (10^6 cfu)
Trial: 7658089
Drug: CVD 112
RxNorm normalized name: Vibrio cholerae CVD 103-HGR strain live antigen Oral Suspension [Vaxchora]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CVD 112 vaccine
Trial: 2527546
Drug: Cilazapril and
RxNorm normalized name: cilazapril and diuretics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cilazapril and Hydrochlorothiazide (combination)
Trial: 1104411
Drug: Prednisone 20
RxNorm normalized name: prednisone 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prednisone 20 mg daily (Pred)
Trial: 1104411
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of prednisone 10 mg and azathioprine 50 mg daily (Comb)
Trial: 28527657
Drug: Brief guided
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Brief guided parent-delivered cognitive behavioural therapy (CBT)
Trial: 28527657
Drug: Solution-focused brief
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Solution-focused brief therapy
Trial: 24764200
Drug: Paroxetine (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paroxetine (10 mg/d) coadministration
Trial: 15045129
Drug: Enoxaparin 1
RxNorm normalized name: ENOXAPARIN 100MG/ML INJ
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enoxaparin 1 mg/kg BW s.c. b.i.d.
Trial: 15045129
Drug: i.v. heparin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: i.v. heparin aPTT‐adjusted daily for 8 +/- 2 days
Trial: 7962286
Drug: Prolonged dopamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prolonged dopamine infusion (5 micrograms/kg.min, iv)
Trial: 7962286
Drug: Brief dopamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Brief dopamine administration (15‐ to 21‐h)
Trial: 16508259
Drug: Dopamine infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dopamine infusion
Trial: 3604396
Drug: Live rubella
RxNorm normalized name: Rubella, live attenuated
DrugBank: Rubella virus vaccine (DB10317)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Live rubella vaccine
Trial: 23312567
Drug: Iloperidone (24
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iloperidone (24 mg/d, mean dose = 21.6 mg)
Trial: 23312567
Drug: Iloperidone (12
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iloperidone (12 mg/d, given once daily at bedtime)
Trial: 18458356
Drug: Sodium Bicarbonate
RxNorm normalized name: Sodium Bicarbonate
DrugBank: Sodium bicarbonate (DB01390)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sodium Bicarbonate (NaHCO(3)) 0.3 g/kg
Trial: 12665753
Drug: Epinephrine injection
RxNorm normalized name: epinephrine Injection
DrugBank: Epinephrine (DB00668)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Epinephrine injection plus heat probe coagulation
Trial: 12665753
Drug: Epinephrine injection
RxNorm normalized name: epinephrine Injection
DrugBank: Epinephrine (DB00668)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Epinephrine injection plus argon plasma coagulation
Trial: 19263664
Drug: Topical application
RxNorm normalized name: Talc Topical application Powder
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical application of fluor gel
Trial: 11207224
Drug: Restrictive red
RxNorm normalized name: acid red 35
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Restrictive red blood cell transfusion guidelines without erythropoietin administration
Trial: 18760492
Drug: Erythropoietin administration
RxNorm normalized name: Erythropoietin
DrugBank: Erythropoietin (DB00016)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Erythropoietin administration
Trial: 9681219
Drug: Chemotherapy (ABVD:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy (ABVD: adriamycin, bleomicin, vinblastine and dacarbazine, 6 monthly cycles)
Trial: 8008405
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg of morphine
Trial: 2809191
Drug: Ketanserin (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketanserin (20 or 40 mg twice a day for 12 weeks)
Trial: 6137857
Drug: Zopiclone 5
RxNorm normalized name: zopiclone 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zopiclone 5 mg
Trial: 6996815
Drug: Zopiclone 9
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zopiclone 9 mg
Trial: 6996815
Drug: Zopiclone 13.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zopiclone 13.5 mg
Trial: 6996815
Drug: Zopiclone (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zopiclone (all doses)
Trial: 31476741
Drug: L-Amino Acid
RxNorm normalized name: L-α-amino-γ-methylmercaptobutyric acid
DrugBank: Methionine (DB00134)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: L-Amino Acid (L-AA)
Trial: 31476741
Drug: L-AA and
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-AA and CGMP-AA (immediate post-consumption)
Trial: 28330721
Drug: Vitamin D3
RxNorm normalized name: Vitamin D3
DrugBank: Cholecalciferol (DB00169)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D3 (20,000 IU weekly)
Trial: 25082115
Drug: Integrative cognitive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Integrative cognitive behavioural therapy for prolonged grief (PG‐CBT), 20‐25 sessions
Trial: 2927990
Drug: Low-dose nebulized
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose nebulized albuterol (0.05 mg/kg per dose)
Trial: 31331773
Drug: Pentavac SD®
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pentavac SD® vaccine
Trial: 23425751
Drug: Daily administration
RxNorm normalized name: Prevpac 30mg-500mg-500mg Daily Administration Pack
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily administration of the Confusion‐Assessment Method for ICU (intervention service)
Trial: 2644923
Drug: Extended course
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Extended course of moxalactam (1 g intravenously for eight doses)
Trial: 2644923
Drug: Both groups
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both groups (single dose and extended course)
Trial: 1090358
Drug: Oral 5-FU
RxNorm normalized name: 5-FU
DrugBank: Fluorouracil (DB00544)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Oral 5-FU (20 mg/kg/day for 5 days)
Trial: 1090358
Drug: Intravenous 5-FU
RxNorm normalized name: 5-FU
DrugBank: Fluorouracil (DB00544)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intravenous 5-FU (13.5 mg/kg/day for 5 days)
Trial: 1090358
Drug: Oral 5-FU
RxNorm normalized name: 5-FU
DrugBank: Fluorouracil (DB00544)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Oral 5-FU (for malignant hepatomegaly)
Trial: 1090358
Drug: Intravenous 5-FU
RxNorm normalized name: 5-FU
DrugBank: Fluorouracil (DB00544)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intravenous 5-FU (for malignant hepatomegaly)
Trial: 21947318
Drug: Pregabalin (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pregabalin (300 mg/day)
Trial: 26721012
Drug: Group A
RxNorm normalized name: Blood group A IgM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group A - Lingual flap retraction in addition to buccal flap
Trial: 17909718
Drug: Steroid group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Steroid group (30 mg/kg BW methylprednisolone intravenously)
Trial: 14973302
Drug: Telithromycin (any
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Telithromycin (any dosage)
Trial: 3554085
Drug: Postoperative chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Postoperative chemotherapy (MeCCNU + 5‐FU)
Trial: 26094549
Drug: Calcipotriol/betamethasone dipropionate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcipotriol/betamethasone dipropionate gel (two‐compound gel) applied once daily
Trial: 26094549
Drug: Calcipotriol scalp
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcipotriol scalp solution applied twice daily
Trial: 26094549
Drug: Calcipotriol/betamethasone dipropionate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcipotriol/betamethasone dipropionate gel (two‐compound gel)
Trial: 19286847
Drug: Febuxostat 120
RxNorm normalized name: Febuxostat 120 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Febuxostat 120 mg
Trial: 1612362
Drug: Calcium carbonate
RxNorm normalized name: Calcium Carbonate
DrugBank: Calcium carbonate (DB06724)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Calcium carbonate 2000 mg daily for 30 days
Trial: 1612362
Drug: Calcium 2000
RxNorm normalized name: calcium gluconate
DrugBank: Calcium gluconate (DB11126)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Calcium 2000 mg daily for 4 weeks
Trial: 28289280
Drug: l‐methylfolate 15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: l‐methylfolate 15 mg
Trial: 24258313
Drug: Intermittent treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intermittent treatment (IT) with cyproterone acetate (CPA) 100 mg tid
Trial: 24258313
Drug: Continuous treatment
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous treatment (CT) with cyproterone acetate (CPA) 100 mg tid
Trial: 18931625
Drug: Intermittent treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intermittent treatment (IT)
Trial: 24258313
Drug: Intermittent treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intermittent treatment (IT) and Continuous treatment (CT)
Trial: 16002451
Drug: Growth Hormone
RxNorm normalized name: Growth hormone
DrugBank: Somatotropin (DB00052)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Growth Hormone (GH) administration (7.5 IU or 2.5 mg)
Trial: 31321800
Drug: 1,540 nm
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1,540 nm fractional erbium-glass laser therapy plus topical minoxidil solution applied twice daily for 6 weeks
Trial: 31321800
Drug: Topical minoxidil
RxNorm normalized name: MINOXIDIL 50 mg in 1 mL TOPICAL SOLUTION [Stafenit Hair Regrowth Treatment Topical Minoxidil]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical minoxidil solution only
Trial: 30646142
Drug: Long-term nicotine
RxNorm normalized name: benzethonium
DrugBank: Benzethonium (DB11125)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Long-term nicotine replacement therapy (LT-NRT) for 12 months with 6 follow-up counseling sessions
Trial: 30646142
Drug: Standard smoking
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard smoking cessation (SSC) treatment for 10 weeks with 4 follow-up counseling sessions
Trial: 24715706
Drug: ACE-536 (0.0625-0.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ACE-536 (0.0625-0.25 mg/kg)
Trial: 24715706
Drug: ACE-536 (0.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ACE-536 (0.25 mg/kg)
Trial: 19443133
Drug: Waiting list
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Waiting list for methadone treatment
Trial: 1916869
Drug: Two-hour infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Two-hour infusion of amphotericin B
Trial: 1916869
Drug: Four-hour infusion
RxNorm normalized name: Four-Way
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Four-hour infusion of amphotericin B
Trial: 7044099
Drug: CMF chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CMF chemotherapy (cyclophosphamide, methotrexate, and 5‐fluorouracil)
Trial: 30865794
Drug: 1-month regimen
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: 1-month regimen of daily rifapentine plus isoniazid
Trial: 22042247
Drug: 250-μg SS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 250-μg SS (scarification of the skin)
Trial: 9811072
Drug: Higher inspired
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Higher inspired oxygen (0.25 L/min higher than baseline, SaO2 >97%)
Trial: 2523644
Drug: Isradipine (once-daily)
RxNorm normalized name: Isradipine
DrugBank: Isradipine (DB00270)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Isradipine (once-daily)
Trial: 2523644
Drug: Isradipine (twice-daily)
RxNorm normalized name: Isradipine
DrugBank: Isradipine (DB00270)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Isradipine (twice-daily)
Trial: 7340890
Drug: Atenolol 200
RxNorm normalized name: Atenolol
DrugBank: Atenolol (DB00335)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Atenolol 200 mg once daily
Trial: 506802
Drug: Atenolol (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atenolol (100 mg and 200 mg)
Trial: 15723894
Drug: Graded exercise
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Graded exercise therapy
Trial: 19704401
Drug: Limited sampling
RxNorm normalized name: gabapentin
DrugBank: Gabapentin (DB00996)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Limited sampling strategies (LSS) for estimation of mycophenolic acid (MPA) AUC(0-12) after EC-MPS administration
Trial: 17972276
Drug: High-dose glycine
RxNorm normalized name: Glycine
DrugBank: Glycine (DB00145)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: High-dose glycine (0.8 g/kg)
Trial: 24061557
Drug: Low-carbohydrate (L-CHO)
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-carbohydrate (L-CHO) diet
Trial: 9291244
Drug: Heparin and
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin and aspirin (current antithrombotic management)
Trial: 7706179
Drug: Aspoxicillin 4
RxNorm normalized name: Amoxicillin
DrugBank: Amoxicillin (DB01060)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aspoxicillin 4 g tds (n = 52)
Trial: 7706179
Drug: Piperacillin 4
RxNorm normalized name: piperacillin 4000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Piperacillin 4 g qds (n = 53)
Trial: 3110654
Drug: Tiaprofenic acid
RxNorm normalized name: tiaprofenic acid
DrugBank: Tiaprofenic acid (DB01600)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tiaprofenic acid (600 mg per diem b.i.d.)
Trial: 3110654
Drug: Lysine acetylsalicylate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lysine acetylsalicylate (1800 mg per diem b.i.d.)
Trial: 18299305
Drug: Cold-adapted influenza
RxNorm normalized name: INFLUENZA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cold-adapted influenza vaccine, trivalent, administered intranasally, 2 doses, 35 +/- 7 days apart.
Trial: 18299305
Drug: Placebo administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo administered intranasally, 2 doses, 35 +/- 7 days apart.
Trial: 3888864
Drug: S-adenosylmethionine (SAMe)
RxNorm normalized name: S-adenosylmethionine
DrugBank: Ademetionine (DB00118)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: S-adenosylmethionine (SAMe) 400 mg thrice daily for 30 days
Trial: 3888864
Drug: Ibuprofen 400
RxNorm normalized name: ibuprofen 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibuprofen 400 mg thrice daily for 30 days
Trial: 20545388
Drug: Placebo with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo with CM-MEDICATION condition
Trial: 15951873
Drug: Aspirin (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin (300 mg daily for 12 weeks)
Trial: 373105
Drug: Pirenzepine (75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pirenzepine (75 mg/day)
Trial: 6096154
Drug: Cimetidine (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cimetidine (1 g/day)